Could a cotton plant compound help beat drug-resistant colon cancer?
NCT ID NCT07337551
First seen Jan 13, 2026 · Last updated Apr 30, 2026 · Updated 16 times
Summary
This study tests a combination of three drugs—gossypol acetate (from cotton plants), bevacizumab, and FOLFIRI—in 20 adults with a specific type of advanced colorectal cancer that has a TP53 mutation and LRPPRC protein. The goal is to see if this mix can shrink tumors or slow the cancer after first-line treatment failed. Participants will receive the combo until the cancer worsens or side effects become too severe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH METASTATIC COLORECTAL CANCER WHO WERE TP53-MUTANT AND LRPPRC-POSITIVE AND HAD PREVIOUSLY FAILED PRIOR FIRST-LINE TREATMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.